Interleukin-18, rheumatoid arthritis, and tissue destruction
Open Access
- 15 November 1999
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 104 (10) , 1337-1339
- https://doi.org/10.1172/jci8731
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A proinflammatory role for IL-18 in rheumatoid arthritisJournal of Clinical Investigation, 1999
- IL-18 Inhibits Diabetes Development in Nonobese Diabetic Mice by Counterregulation of Th1-Dependent Destructive InsulitisThe Journal of Immunology, 1999
- Interleukin-1?-converting enzyme/caspase-1 in human osteoarthritic tissues: Localization and role in the maturation of interleukin-1? and interleukin-18Arthritis & Rheumatism, 1999
- Bioactive IL-18 Expression Is Up-Regulated in Crohn’s DiseaseThe Journal of Immunology, 1999
- Interleukin-18 Binding ProteinImmunity, 1999
- Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor.Journal of Clinical Investigation, 1998
- Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells.Journal of Clinical Investigation, 1998
- Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-γ production from activated B cellsProceedings of the National Academy of Sciences, 1997
- Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritisNature Medicine, 1997
- Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2.Journal of Clinical Investigation, 1997